SHARECARE INC (SHCR)
US81948W1045 - Common Stock
Taking everything into account, SHCR scores 2 out of 10 in our fundamental rating. SHCR was compared to 40 industry peers in the Health Care Technology industry. The financial health of SHCR is average, but there are quite some concerns on its profitability. While showing a medium growth rate, SHCR is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
SHCR had negative earnings in the past year.
SHCR had a negative operating cash flow in the past year.
SHCR had negative earnings in each of the past 5 years.
In multiple years SHCR reported negative operating cash flow during the last 5 years.
1.2 Ratios
SHCR has a Return On Assets of -20.95%. This is comparable to the rest of the industry: SHCR outperforms 56.41% of its industry peers.
SHCR has a better Return On Equity (-26.32%) than 61.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.95% | ||
| ROE | -26.32% | ||
| ROIC | N/A |
ROA(3y)-16.38%
ROA(5y)N/A
ROE(3y)-20.16%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 42.84%, SHCR is doing worse than 66.67% of the companies in the same industry.
SHCR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for SHCR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 42.84% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.69%
GM growth 5YN/A
2. Health
2.1 Basic Checks
SHCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SHCR has been reduced compared to 1 year ago.
Compared to 1 year ago, SHCR has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -0.07, we must say that SHCR is in the distress zone and has some risk of bankruptcy.
SHCR has a Altman-Z score (-0.07) which is in line with its industry peers.
SHCR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, SHCR is in the better half of the industry, outperforming 74.36% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.07 |
ROIC/WACCN/A
WACC10.69%
2.3 Liquidity
SHCR has a Current Ratio of 2.30. This indicates that SHCR is financially healthy and has no problem in meeting its short term obligations.
SHCR's Current ratio of 2.30 is in line compared to the rest of the industry. SHCR outperforms 51.28% of its industry peers.
A Quick Ratio of 2.30 indicates that SHCR has no problem at all paying its short term obligations.
SHCR has a Quick ratio (2.30) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.3 | ||
| Quick Ratio | 2.3 |
3. Growth
3.1 Past
The earnings per share for SHCR have decreased by -8.82% in the last year.
The Revenue has been growing slightly by 0.65% in the past year.
SHCR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.63% yearly.
EPS 1Y (TTM)-8.82%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-42.86%
Revenue 1Y (TTM)0.65%
Revenue growth 3Y10.63%
Revenue growth 5YN/A
Revenue growth Q2Q-14.62%
3.2 Future
The Earnings Per Share is expected to grow by 30.46% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 5.10% on average over the next years.
EPS Next Y15.92%
EPS Next 2Y8.94%
EPS Next 3Y30.46%
EPS Next 5YN/A
Revenue Next Year-5.29%
Revenue Next 2Y1.51%
Revenue Next 3Y5.1%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SHCR. In the last year negative earnings were reported.
Also next year SHCR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
SHCR's earnings are expected to grow with 30.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.94%
EPS Next 3Y30.46%
5. Dividend
5.1 Amount
SHCR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SHARECARE INC
NASDAQ:SHCR (5/3/2024, 7:18:09 PM)
After market: 0.7445 0 (0%)0.7445
+0 (+0.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap269.66M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.95% | ||
| ROE | -26.32% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 42.84% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.3 | ||
| Quick Ratio | 2.3 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-8.82%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y15.92%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)0.65%
Revenue growth 3Y10.63%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y